Invited Presentations July 1, 2001 – June 30, 2004
Dr. Michelle Alfa
“Infection Control Issues Related to Reprocessing Medical Devices”. Presented at the FUDESA Conference. Buenos Aires, Argentina. October 15 – 16, 2004.
“Infection Control in the GI-Unit; Value of Routine Bioburden Testing for Flexible Endoscopes”. Presented at the Canadian Society of Gastroenterology Nurses and Associates 20th Annual Conference. Calgary, Alberta. Sept. 22 – 26, 2004.
“Battling the Bugs with Antiseptics and Disinfectants”. Presented at the Infection Prevention and Control Conference – CHICA. Winnipeg, Manitoba. June 11, 2004.
“Reprocessing of Lummened Instruments” – Meet the Expert; Flexible Endoscopes”. Presented at the 31st Annual Education Conference and International Meeting. Phoenix, Arizona. June 6 – 10, 2004.
“Endoscopy Reprocessing, Problem Areas and Prevention”. Presented at the Reprocessing of Medical Devices: Multi-use and Single-Use Conference – Ontario Hospital Association. Toronto, Ontario. April 1 – 2, 2004.
“Reprocessing of flexible endoscopes not designated to be sterile”. Presented at the International Congress of the German Society for Hospital Hygiene. Berlin, Germany. April 4 – 7, 2004.
“Endoscope Reprocessing Problem Areas & Prevention Strategies”. Presented at the Webber Training and Teleconference. February 12, 2004.
“Cleaning of Reusable Medical Devices”. Presented at the Webber Training and Teleconference. October 9, 2003.
“Early Onset Sepsis in Neonates”. Presented at the Manitoba Congress (MSMLT). Brandon, Manitoba. October 7, 2003.
“Infection Control and GI Endoscopy: The New Scoop on Some Old Poop!”. Presented at the Canadian Society of Gastroenterology Nurses and Associates (CSGNA) Annual Conference. Toronto, Ontario. September 18 – 20, 2003.
“Challenges Associated with Adequate Cleaning of Reusable Narrow-Lumen Medical Devices”. Presented at the Food and Drug Administration. Washington, D.C. May 14, 2003.
“Reprocessing of Flexible Endoscopes: What’s New up the Wazoo”, and “Cleaning Issues for Narrow Lumen Laparascopic Devices”. Presented at the International Association of Healthcare Central Service Materiel Management (IAHCSMM) Meeting. Branson, Michigan. April 27-30, 2003.
“Endoscope Reprocessing”. Presented at the SciCan Inc. Continuing Education Evening, Halifax, NS. February 18, 2003.
“Safe Reprocessing of Single-Use Medical Devices: Is there evidence to direct best practice?” Presented at the Ontario Hospital Association Conference on Reuse of Single-Use Medical Devices. Toronto, Ontario. February 1, 2003
“Reprocessing of Narrow Lumen Medical Devices”. Presented at the Webber Training and Teleconference. December 5, 2002.
“Effects of organic and inorganic material or the efficiency of sterilization processes”. Presented at the 2nd Pan-American Congress on Sterilization. Lima, Peru. November 13 - 15, 2002.
“Reprocessing of Narrow Lumen Medical Devices”, and “Cardiac Catheter; Reprocessing issues”. Presented at the Sterilization and Disinfection Symposium. Sao Paul, Brazil. July 25 - 27, 2002.
“Medical Device Reprocessing Issues Related to CJD”. Presented at the Annual APIC meeting, Michigan Chapter. Southfield, Michigan. July 30, 2002.
“Infection Control Issues Related to Device Reprocessing”. Presented at the Golden Gate Central Processing Association Seminar 2002. Emeryville, California. January 25, 2002.
“Mysteries of Handwashing”. Presented at the Annual Educational Conference for the Canadian Institute of Public Health Inspectors. Toronto. May 2-3, 2002.
“Waterless Handwash and Gloving”. Presented at the 4th Annual Conference of Windsor-Essex Infection Control and Prevention Committee. Windsor, Ontario. September 19, 2001.
“Reuse of Single-use Medical Devices”. Presented at the 1st International Conference of the South Chile Society of O.R. Nurses & Sterilization. Vina del Mar, Chile. August 29-31, 2001.
“Safe Reprocessing of Narrow Lumened Medical Devices”. Presented at the American Hospital Association Conference. Washington. Aug. 15 - 18, 2001.
“Reprocessing of Flexible Endoscopes; What’s New Up the Wazoo!”. Presented at the American Hospital Association Conference. Washington, D.C. August 15 - 18, 2001.
“Safe Reprocessing of Narrow Lumened Medical Devices”. Presented at the International Federation of Sterile Supply. Kuala Lumpur. Mar 26 - 29, 2001.
“Cleaning Methods and Validation Issues”. Presented at the Recent Advances in Central Service Sterilization Sciences. Kuala Lumpur, Malaysia. March 25, 2001.
“Handwashing, Gloving and Waterless Handwash”. Presented at the Southwestern Ontario Practitioners of Infection control Conference. May 30, 2001.
Anton Andonov
Food and Drug Administration, Blood Products Advisory Committee, 76th Meeting, June19-20, 2003. Gaithersburg, MD, US. “SARS: Canadian studies (epidemiology and virology), implications for blood safety”.
VIII European Congress of the International Society of Blood Transfusion, July 5-9, 2003, Istanbul, Turkey. State of the art lecture; “The virological aspects of SARS Coronavirus”.
Fred Aoki
Sept 21, 2000: Non-HIV viral infection in pregnancy. District VI of the American College of Obstetricians and Gynecologists Annual Meeting, Winnipeg, MB.
May 30, 2001: Influenza vaccines – new developments. Immunization Progress and Challenges 2001, Communicable Disease Control Unit, Manitoba Health’s Immunization Conference, Winnipeg, MB.
Feb 2, 2002: Ontario Thoracic Society Better Breathing Symposium, Toronto, ON.
Feb 10, 2002: Neuraminidase inhibitors: controlled trials. Forum on Respiratory Infections, Monte Carlo.
June 22, 2003: Rabies: Post-exposure Prophylaxis. Canadian Association of Emergency Medicine Physicians, Winnipeg, MB.
Sept 17, 2003: Influenza Immunization for Health Care Workers. WRHA Immunization Conference, Winnipeg, MB.
Jan 31, 2004: Update on Infectious Diseases. Hoffmann-La Roche Ltd., Toronto, ON
Apr 16, 2004: Update on Genital Herpes. Department of Family Medicine, Faculty of Medicine, University of Manitoba, Winnipeg, MB.
Apr 22, 2004: 21st Century Epidemics: Influenza. The Manitoba College of Family Physicians, Winnipeg, MB.
Apr 22, 2004: Pneumococcal Disease in Manitoba and Canada. Manitoba Immunization and Travel Conference, Winnipeg, MB.
Harvey Artsob
2001. Potential benefits of microsystem/nanotechnology in global defence against various forms of bioterrorism. Meeting on Microsystems and Nanotechnology organized by NRC and Microsystems Technology Research Institute, November 11-13, Banff, Alberta.
2002. Plenary summary on Public Health, Preparedness and Response at Meeting on Biological Terrorism: Canadian Research Agenda sponsored by Canadian Institutes of Health Research and Health Canada, January 18-20, Toronto, Ontario.
2002. Zoonotic Disease risks in Canada. Occupational Safety and Health Workshop ‘02, February 27-28, Edmonton, Alberta.
2002. West Nile virus: an exotic virus newly introduced into North America and potential threat to Manitoba. Mid-Canada Section, AOAC International, March 12, Winnipeg, Manitoba.
2002. Incursion of West Nile virus into North America. National Conference of Environmental Health Officers and First Nations, March 25-26, Vancouver, British Columbia.
2002. Lyme disease in Manitoba. Wellness Expo, May 4, Winnipeg, Manitoba.
2002. West Nile virus: can exotic arthropod-borne agents make permanent residence in Canada? UWO Stanier Symposium 2002. Linking Hygiene to Health: Old Foes and New Challenges. May 10, London, Ontario.
2002. Overview of the level 4 facility and work being performed at the National Microbiology Laboratory in Winnipeg. Canadian Laboratory Medicine Congress 2002, May 19-23, Calgary, Alberta.
2002. Canadian activities pertaining to dengue virus diagnostics. Dengue Net meeting coordinated by The Pan American Health Organization. July 9-11, San Juan, Puerto Rico.
2002. Emerging Zoonotic Diseases. October 15, University of Manitoba Bug Day, Winnipeg, Manitoba.
2002. West Nile: a virus no longer exotic to North America. Manitoba Congress of Medical Laboratory Science, October 31-November 2, Winnipeg, Manitoba.
2003. National Microbiology Laboratory smallpox testing preparedness. Smallpox Modelling Think Tank, January 16-17, Aylmer, Quebec.
2003. Canadian activities in response to a possible bioterrorist event. Centre for Defence and Security Studies, February 5, Winnipeg, Manitoba.
2003.West Nile virus - lessons learned in 2002 and preparations for 2003. TIBDN (Toronto Invasive Bacterial Diseases Network) Spring Education Day, March 7, Toronto, Ontario.
2003.West Nile virus in North America: infectious disease history in the making. Manitoba College of Family Physicians Inc, 45th Annual Scientific Assembly, April 10-12, Winnipeg, Manitoba.
2003. West Nile virus. HIV counsellors network meeting. May 22, Winnipeg, Manitoba.
2003. The effect of West Nile virus on the health care system - laboratory testing, a national perspective. Ontario Hospital Association. June 16, Hamilton, Ontario.
2003. West Nile virus update. Annual meeting of Canadian Association of Emergency Physicians, June 14-17, Winnipeg, Manitoba.
2003. The new epidemics - SARS, West Nile virus and mad cow disease. Weizmann Women and Science. Weizmann Canada, September 16, Toronto, Ontario.
2003. The new epidemics - SARS and West Nile virus. The Canadian Society for the Weizmann Institute of Science. September 18, Ottawa, Ontario.
2003. Zoonotic diseases - emerging and re-emerging threats. Manitoba Business of Science Symposium, October 9, Winnipeg, Manitoba.
2003. Emerging zoonotic diseases. American College of Physicians. Manitoba-Saskatchewan chapter scientific meeting. November 1-2, Winnipeg, Manitoba.
2004. West Nile: will this emerging disease impact on British Columbia in 2004? British Columbia West Nile Virus Planning Meeting, January 27, Vancouver, British Columbia.
2004. West Nile virus research and long-term implications should WNV become endemic. First Nations Inuit Health Branch (FNIHB) West Nile Planning Meeting, February 4, Ottawa, Ontario.
2004. Zoonotic Diseases: A Canadian perspective. Ontario Veterinary Medical Association Conference, February 5, Ottawa, Ontario.
2004. West Nile: Biology of an emerging flavivirus. Health Products and Food Branch/Biologics and Genetic Therapies Directorate (HPFB/BGTD) West Nile virus workshop, February 18-19, Aylmer, Quebec.
2004. Status of hygiene: perspectives in relation to emergent and re-emergent infections. Stanier Workshop & Public Discussion meetings, February 26-27, Vancouver, British Columbia.
2004. Vector-borne flaviviral diseases due to West Nile, dengue and yellow fever viruses. Manitoba Immunization & Travel Health Conference, April 22-23, Winnipeg, Manitoba.
2004. Control strategies for emerging zoonotic diseases: implementation of generic safety measures, WHO/FAO/OIE Joint Consultation on Emerging Zoonotic Diseases, May 3-5, Geneva, Switzerland.
2004. Emerging/non-emerging arboviral diseases and the veterinary/public health interface. Canadian Animal Health Laboratories Network 3rd Annual Meeting. May 16-19, Guelph, Ontario.
2004. Bioterrorism Tier 1 laboratory training. Canadian Society of Medical Laboratory Science. June 13-16, Saskatoon, Saskatchewan.
Kathryn Bernard
Bioterrorism: Development of a Canadian Laboratory Response Network- a report to Health Canada managers, U of Manitoba Dep’t Med. Microbiology. Hecla Island July 1, 2001
Bioterrorism: Response to BT Agents and an update of HC NML Activities & the HC WG 56th Int. NW Conference on Diseases in Nature Winnipeg MB July 30, 2001
Bacteriologic agents of bioterrorism. Manitoba Conference of Medical Laboratory Sciences, Brandon MB Oct. 2, 2001
Bacteriologic agents of bioterrorism. Red River College lecture, Winnipeg MB Oct. 11, 2001
Laboratory Response to Bioterrorism. An update from the Health Canada working group CACMID 69th Conjoint Meeting on Infectious Diseases November 7, 2001, Victoria BC
Agents of Bioterrorism: Laboratory Issues 101. In Bioterrorism and Public Health: Investigation and Control CEPR-Health Canada. Dec. 12-13, 2001
Bioterrorism: a Briefing for the Canadian Public Health Laboratory Forum. Winnipeg, MB Nov. 21, 2001
Laboratory Response to Bioterrorism. An update from the Health Canada working group NML /U of Manitoba lecture series Jan. 10, 2002
Biological Agents of Concern. ERAP training workshop, Ottawa Feb.13-15, 2002
Laboratory Response to Anthrax in Environmental Specimens AOAC Mid-Canada meeting Winnipeg MB March 12, 2002
Overview of Laboratory Response to the bacterial agents of Bioterrorism Specimens National Research Council Winnipeg MB April 12, 2002
Bioterrorism 101: part of the Biotech Alive! Lecture Series for senior high school students April 19, 2002
Creating a network of microbiology laboratories for bioterrorism response- the Canadian experience. International Union of Microbiological Societies Paris, France July 28, 2002
G-8 Summit: Lessons Learned. A report to the CPHLN meeting Sept. 19, 2002
Bioterrorism Preparedness in Canada: An update on laboratory planning. CACMID Conference, Halifax NS November 6, 2002
Detection and Triage of bacterial agents of bioterrorism at the Canadian federal reference centre. Biosecurity Summit 2002. Las Vegas, NV. November 19, 2002
Bioterrorism Preparedness in Canada An Overview. Centre for Defence and Security Studies, University of Manitoba Winnipeg MB. Feb. 5, 2003
Agents of Bioterrorism-Laboratory based procedures for Canadian Tier 1 facilities. April 2003, Red River College Winnipeg MB.
Decontamination Issues with the Agents of Bioterrorism- Environment Canada Meeting of CRTI 02-0067RD participants Ottawa Ont. June 26 2003
Bioterrorism: an overview of the higher risk agents and Canadian response options. Part of the symposium, Asymmetric threats: Canada and Beyond. Centre for Defence and Security Studies, University of Manitoba, Winnipeg, MB July 11, 2003
Opportunities for biotechnology in biodefence. Business of Science Symposium, Winnipeg MB Oct. 9 2003
Bioterrorism: roles of Health Canada and members of the CPHLN. Department of Medical Microbiology University of Manitoba, Winnipeg MB Oct 23, 2003
Biological weapons, the environment, human health and bioterrorism response. Environmental Symposium, Queen’s University Kingston Ont. Feb 7 2004
Bioterrorism Overview of the creation of a response network and recognition of Tier 1 agents. Red River College, faculty of Medical Laboratory Technology, as guest lecturer June 2 2004
An overview of Bioterrorism response- Workplace Health and Public Safety Programme Visit by federal officers. June 25 2004 at the NML, Winnipeg.
Revisiting the genus Corynebacterium with emphasis on C. diphtheriae. Dep’t Medical Microbiology, U of Manitoba, Winnipeg MB Feb. 6, 2002
Corynebacterium species Queen’s University-Kingston General Hospital, Kingston Ont Feb 6 2004
Review of Corynebacterium diphtheriae or C. ulcerans isolates in Canada from cases which were not consistent with notifiable disease criteria. L De Winter and K. Bernard (presented by LDW), 8th international meeting of the European Working Group on Diphtheria. June 16-18, 2004 Copenhagen Denmark
Jody Berry
(2002) Novel Strategies for the rapid generation of monoclonal antibodies. University of Manitoba Dean of Medicine Quarterly Research Forum. Canadian Science Centre for Human and Animal Health. Winnipeg, February 8.
(2002) The Monoclonal Antibody Facility at the National Centre for Foreign Animal Disease. Red River Community College, Winnipeg, October 22.
(2003) Antibody Libraries from Immune Repertoires: The development of monoclonal Antibody to Infectious Agents. Faculty Research Seminar. Department of Medical Microbiology, University of Manitoba. January 29.
(2003) The Development of Recombinant Monoclonal Antibodies (MAbs) for Treatment and Detection of BioTerrorism Agents [BTA]. CRTI Spring Symposium. June 25. Chateau Gatineau, QE.
(2003) Therapeutic monoclonal antibodies to SARS coronavirus. Current Science of SARS symposium, National Microbiology Laboratory, Winnipeg, Manitoba, Canada.December 1.
(2004) The Development of recombinant monoclonal antibodies for the treatment and detection of Bio-terrorism agents. Biological and Chemical Defence review committee, National Microbiology Laboratory, Winnipeg, Manitoba, Canada, May 6.
(2004) Immunochemistry and genetics of monoclonal antibodies to SARS-CoV. The National Microbiology Laboratory, Winnipeg, Manitoba, Canada, June 7.
(2004) From the SARS virus to Anthrax toxins: How can we slay these monsters by exploiting host antibody responses? The Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada, June 10.
James Blanchard
July, 2001: “Populations, pathogens and epidemic phases: closing the gap between theory and practices in STI/HIV prevention”. Division of STD Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.